rdf:type |
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0035820,
umls-concept:C0039099,
umls-concept:C0185117,
umls-concept:C0205314,
umls-concept:C0231491,
umls-concept:C0679622,
umls-concept:C1414506,
umls-concept:C2348480,
umls-concept:C2603343,
umls-concept:C2911684
|
pubmed:issue |
3
|
pubmed:dateCreated |
2007-3-21
|
pubmed:abstractText |
Serine proteinases activate the G protein-coupled receptor, proteinase-activated receptor 2 (PAR-2), via cleavage and exposure of a tethered ligand. PAR-2 is known to exert proinflammatory actions in a murine model of arthritis, since PAR-2-deficient mice exhibit strikingly reduced articular inflammation. This study was undertaken to examine synovial PAR-2 expression and to determine the effect of a novel PAR-2 antagonist on synovial cytokine production, in order to investigate the hypothesis that PAR-2 plays a critical role in the pathogenesis of rheumatoid arthritis (RA).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0004-3591
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
765-71
|
pubmed:meshHeading |
pubmed-meshheading:17328048-Adult,
pubmed-meshheading:17328048-Aged,
pubmed-meshheading:17328048-Arthritis, Rheumatoid,
pubmed-meshheading:17328048-Cells, Cultured,
pubmed-meshheading:17328048-Dose-Response Relationship, Drug,
pubmed-meshheading:17328048-Gene Expression Regulation,
pubmed-meshheading:17328048-Humans,
pubmed-meshheading:17328048-Interleukin-1beta,
pubmed-meshheading:17328048-Middle Aged,
pubmed-meshheading:17328048-Piperazines,
pubmed-meshheading:17328048-Receptor, PAR-2,
pubmed-meshheading:17328048-Synovial Membrane,
pubmed-meshheading:17328048-Tumor Necrosis Factor-alpha
|
pubmed:year |
2007
|
pubmed:articleTitle |
Expression and proinflammatory role of proteinase-activated receptor 2 in rheumatoid synovium: ex vivo studies using a novel proteinase-activated receptor 2 antagonist.
|
pubmed:affiliation |
University of Glasgow, Glasgow, UK.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|